Breaking news

n this paper recently published in JAMA, the authors evaluated the prevalence, intensity, and timing of an altered sense of smell or taste in mildly symptomatic patients with SARS-CoV-2 infection.

In this letter, recently published in the European Journal of Neurology, Sellner et al., emphasise that neurologists need to be part of the multidisciplinary team taking care of COVID-19 patients.

In this nice editorial, Prof. Johann Sellner discusses the possible role of translational neuroscience research in the current COVID-19 outbreak.

The current COVID-19 outbreak, caused by the novel SARS-CoV-2, has raised the possibility of potential neurotropic properties of this virus.

The aim of this randomised, double-blind, placebo-controlled, multicentre trial was to analyze the effects of Remdesivir in adult patients with severe COVID-19 infection.

The objective of this parallel, double-masked, randomized, phase IIb clinical trial, was to evaluate the safety and efficacy of 2 chloroquine diphosphate (CQ) dosages in patients with severe COVID-19. 81 adult patients who were hospitalized with SARS-CoV-2 infection were enrolled from March 23 to April 5, 2020, at a tertiary care facility in Manaus, Brazilian Amazon.

In this paper recently published in Movement Disorders, Prasad et al., surveyed the perceptions of 100 patients with Parkinson’s disease (PD) and their caregivers who were under follow-up at the National Institute of Mental Health and Neurosciences, Bengaluru, India on the implications of Covid-19 infection.

In this paper recently published in Movement Disorders, Antonini et al., report the outcome of 10 clinical cases of Parkinson’s Disease patients infected by SARS-CoV-2, collected from the experience at the Parkinson and Movement Disorders Unit in Padua, Italy and the Parkinson’s Foundation Centre of Excellence at King’s College Hospital in London, UK.

In this paper, Baracchini et al., share their single-center experience of the substantial changes in the acute stroke management pathway during the COVID-19 outbreak.

In this special report recently published in Stroke, Smith et al., assembled a multidisciplinary working group to develop consensus-based recommendations and an algorithm for evaluation and treatment of acute stroke patients eligible for endovascular therapy (EVT) during the COVID-19 pandemic, with the goal of minimizing the negative impact of COVID-19 on acute stroke patients and healthcare providers.

In this paper recently published in the Journal of Neurology, Neurosurgery, and Psychiatry, the authors describe the demographic, clinical, radiological and laboratory characteristics of six consecutive patients assessed between 1st and 16th April 2020 at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

In this paper recently published in The New England Journal of Medicine, Oxley et al., report five cases of large-vessel stroke in patients younger than 50 years of age affected by SARS-CoV-2 infection.

In this very useful paper, the European Society of Minimally Invasive Neurological Therapy (ESMINT) gives recommendations for optimal interventional neurovascular management during the covid-19 outbreak. The authors identify some important priorities including: early detection and limiting exposure of healthcare workers… Continue Reading

In this interesting correspondence just published in the Lancet, Varga et al. demonstrate endothelial cell involvement across vascular beds of different organs in a series of patients with COVID-19 finding evidence of direct viral infection of the endothelial cell and… Continue Reading

The aim of this multicenter retrospective study, just published in Epilepsia, was to clarify the incidence and risk of acute symptomatic seizures in people with COVID-19 infection. A total of 304 patients were enrolled, of whom 108 had severe disease,… Continue Reading